Literature DB >> 16595787

Analysis of human antibodies to erythrocyte binding antigen 175 peptide 4 of Plasmodium falciparum.

Fousseyni S Touré1, Philippe Deloron, Florence Migot-Nabias.   

Abstract

BACKGROUND: The IgG1 and IgG3 antibodies are considered cytophilic and protective against Plasmodium falciparum, whereas IgG2 and IgG4 are thought to block protective mechanisms.
OBJECTIVES: The main objective was to measure antibodies directed against erythrocyte binding antigen-175 (EBA-175) peptide 4 and analyze the relationship between such antibodies and clinical malaria attack.
METHODS: Using an enzyme-linked immunosorbent assay, a retrospective analysis of naturally acquired antibodies to synthetic peptide from EBA-175 peptide 4 has been carried out in 158 school children from the village of Dienga in Gabon.
RESULTS: The overall prevalence rates of antibodies to EBA-175 peptide 4 were 85.2%, 66.8%, 52.6%, 71.6% and 64.0% for total IgG, IgG1, IgG2, IgG3 and IgG4, respectively. Protection from clinical malaria, determined after a prospective 1-year study, was associated with the levels of IgG and IgG1 antibodies that increased with age.
CONCLUSION: Together, these data suggest that age/exposure-related acquisition of anti-EBA-175 antibodies may contribute to the development of clinically protective immunity and could be taken into account in malaria control strategies when they are confirmed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16595787      PMCID: PMC1435654          DOI: 10.3121/cmr.4.1.1

Source DB:  PubMed          Journal:  Clin Med Res        ISSN: 1539-4182


  39 in total

1.  IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria.

Authors:  R R Taylor; S J Allen; B M Greenwood; E M Riley
Journal:  Am J Trop Med Hyg       Date:  1998-04       Impact factor: 2.345

2.  Aspects of the molecular structure of IgG subclasses.

Authors:  D R Burton; L Gregory; R Jefferis
Journal:  Monogr Allergy       Date:  1986

3.  A Plasmodium falciparum antigen that binds to host erythrocytes and merozoites.

Authors:  D Camus; T J Hadley
Journal:  Science       Date:  1985-11-01       Impact factor: 47.728

4.  Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria.

Authors:  F al-Yaman; B Genton; R Anders; J Taraika; M Ginny; S Mellor; M P Alpers
Journal:  Parasite Immunol       Date:  1995-09       Impact factor: 2.280

5.  Immune response to Plasmodium falciparum liver stage antigen-1: geographical variations within Central Africa and their relationship with protection from clinical malaria.

Authors:  F Migot-Nabias; P Deloron; P Ringwald; B Dubois; J Mayombo; T N Minh; N Fievet; P Millet; A Luty
Journal:  Trans R Soc Trop Med Hyg       Date:  2000 Sep-Oct       Impact factor: 2.184

6.  Protection of Aotus monkeys by Plasmodium falciparum EBA-175 region II DNA prime-protein boost immunization regimen.

Authors:  T R Jones; D L Narum; A S Gozalo; J Aguiar; S R Fuhrmann; H Liang; J D Haynes; J K Moch; C Lucas; T Luu; A J Magill; S L Hoffman; B K Sim
Journal:  J Infect Dis       Date:  2000-12-08       Impact factor: 5.226

7.  Antibodies against the Plasmodium falciparum receptor binding domain of EBA-175 block invasion pathways that do not involve sialic acids.

Authors:  D L Narum; J D Haynes; S Fuhrmann; K Moch; H Liang; S L Hoffman; B K Sim
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

8.  Identification of an erythrocyte binding peptide from the erythrocyte binding antigen, EBA-175, which blocks parasite multiplication and induces peptide-blocking antibodies.

Authors:  P H Jakobsen; P M Heegaard; C Koch; K Wasniowska; M M Lemnge; J B Jensen; B K Sim
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  A hypothesis about the chronicity of malaria infection.

Authors:  P Druilhe; J L Pérignon
Journal:  Parasitol Today       Date:  1997-09

10.  Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity.

Authors:  E M Riley; S J Allen; J G Wheeler; M J Blackman; S Bennett; B Takacs; H J Schönfeld; A A Holder; B M Greenwood
Journal:  Parasite Immunol       Date:  1992-05       Impact factor: 2.280

View more
  12 in total

1.  Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.

Authors:  Carlota Dobaño; Diana Quelhas; Llorenç Quintó; Laura Puyol; Elisa Serra-Casas; Alfredo Mayor; Tacilta Nhampossa; Eusebio Macete; Pedro Aide; Inacio Mandomando; Sergi Sanz; Sanjeev K Puniya; Bijender Singh; Puneet Gupta; Arindam Bhattacharya; Virander S Chauhan; John J Aponte; Chetan E Chitnis; Pedro L Alonso; Clara Menéndez
Journal:  Clin Vaccine Immunol       Date:  2011-12-14

2.  Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.

Authors:  Faith H A Osier; Gregory Fegan; Spencer D Polley; Linda Murungi; Federica Verra; Kevin K A Tetteh; Brett Lowe; Tabitha Mwangi; Peter C Bull; Alan W Thomas; David R Cavanagh; Jana S McBride; David E Lanar; Margaret J Mackinnon; David J Conway; Kevin Marsh
Journal:  Infect Immun       Date:  2008-03-03       Impact factor: 3.441

3.  Synthetic Antigens Derived from Plasmodium falciparum Sporozoite, Liver, and Blood Stages: Naturally Acquired Immune Response and Human Leukocyte Antigen Associations in Individuals Living in a Brazilian Endemic Area.

Authors:  Lilian Rose Pratt-Riccio; Daiana De Souza Perce-Da-Silva; Josué Da Costa Lima-Junior; Evelyn Kety Pratt Riccio; Marcelo Ribeiro-Alves; Fátima Santos; Mercia Arruda; Daniel Camus; Pierre Druilhe; Joseli Oliveira-Ferreira; Cláudio Tadeu Daniel-Ribeiro; Dalma Maria Banic
Journal:  Am J Trop Med Hyg       Date:  2017-10-10       Impact factor: 2.345

4.  Evaluation of allelic forms of the erythrocyte binding antigen 175 (EBA-175) in Plasmodium falciparum field isolates from Brazilian endemic area.

Authors:  Daiana S Perce-da-Silva; Dalma M Banic; Josué C Lima-Junior; Fátima Santos; Cláudio T Daniel-Ribeiro; Joseli de Oliveira-Ferreira; Lilian R Pratt-Riccio
Journal:  Malar J       Date:  2011-05-26       Impact factor: 2.979

5.  Antibody response against three Plasmodium falciparum merozoite antigens in Mamuju District, West Sulawesi Province, Indonesia.

Authors:  Nurhayana Sennang; Stephen Rogerson; Sitti Wahyuni; Irawan Yusuf; Din Syafruddin
Journal:  Malar J       Date:  2014-09-25       Impact factor: 2.979

6.  Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria.

Authors:  Hodan Ahmed Ismail; Muyideen K Tijani; Christine Langer; Linda Reiling; Michael T White; James G Beeson; Mats Wahlgren; Roseangela Nwuba; Kristina E M Persson
Journal:  Malar J       Date:  2014-11-05       Impact factor: 2.979

7.  High Level of Specific Anti-Plasmodium Falciparum Merozoite IgG1 Antibodies in Rural Asymptomatic Individuals of Dienga, South-Eastern Gabon.

Authors:  Irène Pegha-Moukandja; Roméo-Karl Imboumy-Limoukou; Nina Tchitoula-Makaya; Augustin-Ghislain Mouinga-Ondeme; Jean Claude Biteghe-Bi-Essone; Dieudonne Nkoghe Mba; Jean-Bernard Lekana-Douki; Fousseyni S Toure Ndouo
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2017-12-04

8.  Variations in the quality of malaria-specific antibodies with transmission intensity in a seasonal malaria transmission area of Northern Ghana.

Authors:  Kwadwo A Kusi; Emmanuel A Manu; Theresa Manful Gwira; Eric Kyei-Baafour; Emmanuel K Dickson; Jones A Amponsah; Edmond J Remarque; Bart W Faber; Clemens H M Kocken; Daniel Dodoo; Ben A Gyan; Gordon A Awandare; Frank Atuguba; Abraham R Oduro; Kwadwo A Koram
Journal:  PLoS One       Date:  2017-09-25       Impact factor: 3.240

9.  Acquisition of antibody isotypes against Plasmodium falciparum blood stage antigens in a birth cohort.

Authors:  N O Duah; D J C Miles; H C Whittle; D J Conway
Journal:  Parasite Immunol       Date:  2010-02       Impact factor: 2.280

10.  Potential impact of host immunity on malaria treatment outcome in Tanzanian children infected with Plasmodium falciparum.

Authors:  Anders Enevold; Watoky M M M Nkya; Michael Theisen; Lasse S Vestergaard; Anja Tr Jensen; Trine Staalsoe; Thor G Theander; Ib C Bygbjerg; Michael Alifrangis
Journal:  Malar J       Date:  2007-11-16       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.